Bioscan Research raises $1M seed
Announced 22 July 2026
◆ The Round
Bioscan Research raised $1M in seed funding, announced on 22 July 2026, led by Unicorn India Ventures. The round is tracked live by Fusion42 as part of the Raise fund database and the Scout startup database.
◆ About Bioscan Research
Bioscan Research develops non-invasive, point-of-care medical devices for early detection of brain injuries and intracranial hemorrhage. Its core product, CEREBO, uses optics, electronics, and machine learning to help clinicians and first responders rapidly screen patients in emergency and trauma settings.[3][4][10][12] Bioscan Research is based in India and currently at seed stage, operating in healthtech.
◆ Investors
LeadUnicorn India Ventures
◆ Market context
This funding event is a citable node in Fusion42's market graph: it links Bioscan Research's Scout profile to the funds behind the round and to related Wire analysis, and is refreshed from public announcements as the round is confirmed or extended. It is the same live market data Arthur reasons over when benchmarking a founder's own raise against what is closing in the market right now.
◆ Explore the market
◆ FAQ
How much did Bioscan Research raise?
Bioscan Research raised $1M in its seed round, announced 2026-07-22.
Who invested in Bioscan Research's seed round?
The round was led by Unicorn India Ventures.
What does Bioscan Research do?
Bioscan Research develops non-invasive, point-of-care medical devices for early detection of brain injuries and intracranial hemorrhage. Its core product, CEREBO, uses optics, electronics, and machine learning to help clinicians and first responders rapidly screen patients in emergency and trauma settings.[3][4][10][12]
Verified 22 July 2026 · Sources: public filings